The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Open accessAbstract
Antimicrobial peptides (AMPs) are expressed in various living organisms as first-line host defenses against potential harmful encounters in their surroundings. AMPs are short polycationic peptides exhibiting various antimicrobial activities. The principal antibacterial activity is attributed to the membrane-lytic mechanism which directly interferes with the integrity of the bacterial cell membrane and cell wall. In addition, a number of AMPs form a transmembrane channel in the membrane by self-aggregation or polymerization, leading to cytoplasm leakage and cell death. However, an increasing body of evidence has demonstrated that AMPs are able to exert intracellular inhibitory activities as the primary or supportive mechanisms to achieve efficient killing. In this review, we focus on the major intracellular targeting activities reported in AMPs, which include nucleic acids and protein biosynthesis and protein-folding, protease, cell division, cell wall biosynthesis, and lipopolysaccharide inhibition. These multifunctional AMPs could serve as the potential lead peptides for the future development of novel antibacterial agents with improved therapeutic profiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448 · cited 1×
“LPS can be shed from the cell during the process of infection or the course of antimicrobial chemotherapy treatment (160).”
BackgroundThe expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Pathways of clathrin-independent endocytosis
Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556
Navarre, W. W., & Schneewind, O. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.1.174-229.1999 · Cited by 1,391
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Barrel-Stave Model or Toroidal Model? A Case Study on Melittin Pores
Yang, L., Harroun, T. A., Weiss, T. M., Ding, L., & Huang, H. W. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75802-x · Cited by 1,114
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Cationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978 · cited 1×
“Different classes of AMPs have been discovered in various organisms from mammals, arachnids, amphibians, plants, fungi, and even single-cell microorganisms (6, 7).”
BackgroundThe relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Park, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Mode of action of linear amphipathic α-helical antimicrobial peptides
Oren, Z., & Shai, Y. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<451::aid-bip4>3.0.co;2-f · Cited by 848
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., & Selsted, M. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114198 · Cited by 715
Lipid II as a target for antibiotics
Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701
Lantibiotics: structure, biosynthesis and mode of action
McAuliffe, O. (2001) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(00)00065-6 · Cited by 700
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
Oppenheim, F. G., Xu, T., McMillian, F. M., Levitz, S. M., Diamond, R. D., Offner, G. D., & Troxler, R. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68522-9 · Cited by 652
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
PEPTIDES AS WEAPONS AGAINST MICROORGANISMS IN THE CHEMICAL DEFENSE SYSTEM OF VERTEBRATES
Nicolas, P., & Mor, A. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.001425 · Cited by 564
Toroidal pores formed by antimicrobial peptides show significant disorder
Sengupta, D., Leontiadou, H., Mark, A. E., & Marrink, S.-J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.06.007 · Cited by 563
Boman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
Schneider, T., Kruse, T., Wimmer, R., Wiedemann, I., Sass, V., Pag, U., Jansen, A., Nielsen, A. K., Mygind, P. H., Raventós, D. S., et al. (2010) · Science · doi:10.1126/science.1185723 · Cited by 550
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Hsu, S.-T. D., Breukink, E., Tischenko, E., Lutters, M. A. G., de Kruijff, B., Kaptein, R., Bonvin, A. M. J. J., & van Nuland, N. A. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb830 · Cited by 547
Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils.
Selsted, M. E., Novotny, M. J., Morris, W. L., Tang, Y. Q., Smith, W., & Cullor, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42830-x · Cited by 546
Park, C. B., Yi, K.-S., Matsuzaki, K., Kim, M. S., & Kim, S. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150518097 · Cited by 546
Cole, A. M., Weis, P., & Diamond, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12008 · Cited by 541
Nakamura, T., Furunaka, H., Miyata, T., Tokunaga, F., Muta, T., Iwanaga, S., Niwa, M., Takao, T., & Shimonishi, Y. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37448-9 · Cited by 531
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., de Kruijff, B., & Breukink, E. (2006) · Science · doi:10.1126/science.1129818 · Cited by 501
Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., & Otvos, L. (2001) · Biochemistry · doi:10.1021/bi002656a · Cited by 491
Mechanism of antimicrobial action of indolicidin
Subbalakshmi, C. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00008-1 · Cited by 474
Apidaecins: antibacterial peptides from honeybees.
Casteels, P., Ampe, C., Jacobs, F., Vaeck, M., & Tempst, P. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08368.x · Cited by 469
How do bacteria resist human antimicrobial peptides?
Peschel, A. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02333-8 · Cited by 465
Mode of Action of the Antimicrobial Peptide Indolicidin
Falla, T. J., Karunaratne, D. N., & Hancock, R. E. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19298 · Cited by 461
Streptococcus mutans, Caries and Simulation Models
Forssten, S. D., Björklund, M., & Ouwehand, A. C. (2010) · Nutrients · doi:10.3390/nu2030290 · Cited by 459
Selsted, M. E., Tang, Y. Q., Morris, W. L., McGuire, P. A., Novotny, M. J., Smith, W., Henschen, A. H., & Cullor, J. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53298-1 · Cited by 443
Epithelial Antibiotics Induced at Sites of Inflammation
Schonwetter, B. S., Stolzenberg, E. D., & Zasloff, M. A. (1995) · Science · doi:10.1126/science.7886453 · Cited by 407
Di Nardo, A., Vitiello, A., & Gallo, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2274 · Cited by 405
The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II
Brötz, H., Bierbaum, G., Leopold, K., Reynolds, P. E., & Sahl, H.-G. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.154 · Cited by 381
DnaK Functions as a Central Hub in the E. coli Chaperone Network
Calloni, G., Chen, T., Schermann, S. M., Chang, H.-C., Genevaux, P., Agostini, F., Tartaglia, G. G., Hayer-Hartl, M., & Hartl, F. U. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.12.007 · Cited by 380
Interaction between Heat Shock Proteins and Antimicrobial Peptides
Otvos, O, I., Rogers, M. E., Consolvo, P. J., Condie, B. A., Lovas, S., Bulet, P., & Blaszczyk-Thurin, M. (2000) · Biochemistry · doi:10.1021/bi0012843 · Cited by 370
Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V., & Hancock, R. E. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.605-614.2002 · Cited by 354
AGERBERTH, B., LEE, J., BERGMAN, T., CARLQUIST, M., BOMAN, H. G., MUTT, V., & JÖRNVALL, H. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16442.x · Cited by 348
Microcin 25, a novel antimicrobial peptide produced by Escherichia coli
Salomón, R. A., & Farías, R. N. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.22.7428-7435.1992 · Cited by 341
Hsu, C.-H. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki725 · Cited by 335
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Jones, A. T. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00062.x · Cited by 315
The molecular chaperone concept.
Ellis, R. J. (1990) · PubMed · Cited by 310
Interaction of the Mammalian Antibacterial Peptide Cecropin P1 with Phospholipid Vesicles
Gazit, E., Boman, A., Boman, H. G., & Shai, Y. (1995) · Biochemistry · doi:10.1021/bi00036a021 · Cited by 302
A Novel Antimicrobial Peptide fromBufo bufo gargarizans
Park, C. B., Kim, M. S., & Kim, S. C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0071 · Cited by 298
Thiazole and oxazole peptides: biosynthesis and molecular machinery
Roy, R. S., Gehring, A. M., Milne, J. C., Belshaw, P. J., Walsh, C. T., Roy, R. S., Gehring, A. M., Milne, J. C., Belshaw, P. J., & Walsh, C. T. (1999) · Natural Product Reports · doi:10.1039/a806930a · Cited by 285
Regulation of blood coagulation
Esmon, C. T. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00266-6 · Cited by 283
Human β-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci
Sass, V., Schneider, T., Wilmes, M., Körner, C., Tossi, A., Novikova, N., Shamova, O., & Sahl, H.-G. (2010) · Infection and Immunity · doi:10.1128/iai.00688-09 · Cited by 254
Role of the Escherichia coli SbmA in the antimicrobial activity of proline‐rich peptides
Mattiuzzo, M., Bandiera, A., Gennaro, R., Benincasa, M., Pacor, S., Antcheva, N., & Scocchi, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05903.x · Cited by 248
Rosenberger, C. M., Gallo, R. L., & Finlay, B. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304455101 · Cited by 244
Antiendotoxin activity of cationic peptide antimicrobial agents
Gough, M., Hancock, R. E., & Kelly, N. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.12.4922-4927.1996 · Cited by 244
Mardirossian, M., Grzela, R., Giglione, C., Meinnel, T., Gennaro, R., Mergaert, P., & Scocchi, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.10.009 · Cited by 235
Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model
Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S. O., & Ljungh, Å. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh387 · Cited by 231
Bacterial Wall as Target for Attack: Past, Present, and Future Research
Koch, A. L. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.673-687.2003 · Cited by 231
Friedrich, C. L., Rozek, A., Patrzykat, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009691200 · Cited by 225
Functional interaction of human neutrophil peptide‐1 with the cell wall precursor lipid II
de Leeuw, E., Li, C., Zeng, P., Li, C., Buin, M. D.-D., Lu, W.-Y., Breukink, E., & Lu, W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.004 · Cited by 222
Mukhopadhyay, J., Sineva, E., Knight, J., Levy, R. M., & Ebright, R. H. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.010 · Cited by 214
Kobayashi, S., Takeshima, K., Park, C. B., Kim, S. C., & Matsuzaki, K. (2000) · Biochemistry · doi:10.1021/bi0004549 · Cited by 213
Structure of Antibacterial Peptide Microcin J25: A 21-Residue Lariat Protoknot
Bayro, M. J., Mukhopadhyay, J., Swapna, G. V. T., Huang, J. Y., Ma, L.-C., Sineva, E., Dawson, P. E., Montelione, G. T., & Ebright, R. H. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036677e · Cited by 212
Schnapp, D., Kemp, G. D., & Smith, V. J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0532h.x · Cited by 208
Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (Hippoglossus hippoglossus L.)
Birkemo, G. A., Lüders, T., Andersen, Ø., Nes, I. F., & Nissen-Meyer, J. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(03)00018-9 · Cited by 206
The Lantibiotic Mersacidin Inhibits Peptidoglycan Biosynthesis at the Level of Transglycosylation
Brötz, H., Bierbaum, G., Reynolds, P. E., & Sahl, H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00193.x · Cited by 199
Rahnamaeian, M., Cytryńska, M., Zdybicka-Barabas, A., Dobslaff, K., Wiesner, J., Twyman, R. M., Zuchner, T., Sadd, B. M., Regoes, R. R., Schmid-Hempel, P., et al. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2015.0293 · Cited by 198
Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils
Robinson, W. E., McDougall, B., Tran, D., & Selsted, M. E. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.1.94 · Cited by 197
MacKay, B. J., Denepitiya, L., Iacono, V. J., Krost, S. B., & Pollock, J. J. (1984) · Infection and Immunity · doi:10.1128/iai.44.3.695-701.1984 · Cited by 197
Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions
Schibli, D. J., Epand, R. F., Vogel, H. J., & Epand, R. M. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-147 · Cited by 196
Vizán, J. L., Hernández-Chico, C., del Castillo, I., & Moreno, F. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07969.x · Cited by 195
Cociancich, S., Dupont, A., Hegy, G., Lanot, R., Holder, F., Hetru, C., Hoffmann, J. A., & Bulet, P. (1994) · Biochemical Journal · doi:10.1042/bj3000567 · Cited by 194
Bierbaum, G., & Sahl, H. G. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.12.5452-5458.1987 · Cited by 191
Yeaman, M. R., Bayer, A. S., Koo, S. P., Foss, W., & Sullam, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci562 · Cited by 189
How Does It Kill?: Understanding the Candidacidal Mechanism of Salivary Histatin 5
Puri, S., & Edgerton, M. (2014) · Eukaryotic Cell · doi:10.1128/ec.00095-14 · Cited by 186
Copsin, a Novel Peptide-based Fungal Antibiotic Interfering with the Peptidoglycan Synthesis
Essig, A., Hofmann, D., Münch, D., Gayathri, S., Künzler, M., Kallio, P. T., Sahl, H.-G., Wider, G., Schneider, T., & Aebi, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.599878 · Cited by 179
Structural Relationship Between Human Salivary Histatins
Troxler, R. F., Offner, G. D., Xu, T., Vanderspek, J. C., & Oppenheim, F. G. (1990) · Journal of Dental Research · doi:10.1177/00220345900690010101 · Cited by 177
Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites
Marchand, C., Krajewski, K., Lee, H.-F., Antony, S., Johnson, A. A., Amin, R., Roller, P., Kvaratskhelia, M., & Pommier, Y. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl667 · Cited by 171
Bonelli, R. R., Schneider, T., Sahl, H.-G., & Wiedemann, I. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1449-1457.2006 · Cited by 170
Baquero, F., & Moreno, F. (1984) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1984.tb01046.x · Cited by 170
Molecular Mechanism of Transcription Inhibition by Peptide Antibiotic Microcin J25
Adelman, K., Yuzenkova, J., La Porta, A., Zenkin, N., Lee, J., Lis, J. T., Borukhov, S., Wang, M. D., & Severinov, K. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.05.017 · Cited by 169
The potential for Toll‐like receptors to collaborate with other innate immune receptors
Mukhopadhyay, S., Herre, J., Brown, G. D., & Gordon, S. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01941.x · Cited by 168
Antimicrobial peptides of leukocytes
Ganz, T., & Lehrer, R. I. (1997) · Current Opinion in Hematology · doi:10.1097/00062752-199704010-00009 · Cited by 168
Piers, K. L., Brown, M. H., & Hancock, R. E. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2311 · Cited by 167
Chen, L., Todd, R., Kiehlbauch, J., Walters, M., & Kallen, A. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6601a7 · Cited by 166
Lee, H.-Y., Andalibi, A., Webster, P. C., Moon, S. K., Teufert, K. B., Kang, S. H., Li, J., Nagura, M., Ganz, T., & LIM, D. J. (2004) · BMC Infectious Diseases · doi:10.1186/1471-2334-4-12 · Cited by 160
Apidaecin-type peptides: Biodiversity, structure–function relationships and mode of action
Li, W., Ma, G.-X., & Zhou, X. (2006) · Peptides · doi:10.1016/j.peptides.2006.03.016 · Cited by 157
Ladokhin, A. S., Selsted, M. E., & White, S. H. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78713-7 · Cited by 157
Yoneyama, F., Imura, Y., Ohno, K., Zendo, T., Nakayama, J., Matsuzaki, K., & Sonomoto, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00209-09 · Cited by 154
Stein, T. H., Borchert, S., Conrad, B., Feesche, J., Hofemeister, B., Hofemeister, J., & Entian, K. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.6.1703-1711.2002 · Cited by 154
Inhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide‐Induced Inflammation
Sun, Y., & Shang, D. (2015) · Mediators of Inflammation · doi:10.1155/2015/167572 · Cited by 152
Yonezawa, A., Kuwahara, J., Fujii, N., & Sugiura, Y. (1992) · Biochemistry · doi:10.1021/bi00126a022 · Cited by 150
Mutations of Bacterial RNA Polymerase Leading to Resistance to Microcin J25
Yuzenkova, J., Delgado, M. A., Nechaev, S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209425200 · Cited by 147
Chatterjee, S., Chatterjee, S. K., Lad, S. J., PHANSALKAR, M. S., Rupp, R. H., GANGULI, B. N., Fehlhaber, H., & Kogler, H. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.832 · Cited by 147
Purification and in vitro activities of rabbit platelet microbicidal proteins
Yeaman, M. R., Tang, Y., Shen, A. J., Bayer, A. S., & Selsted, M. E. (1997) · Infection and Immunity · doi:10.1128/iai.65.3.1023-1031.1997 · Cited by 140
Fogaça, A. C., de Almeida, I. C., Eberlin, M. N., Tanaka, A. S., Bulet, P., & Daffre, S. (2005) · Peptides · doi:10.1016/j.peptides.2005.07.013 · Cited by 138
Knappe, D., Piantavigna, S., Hansen, A., Mechler, Á., Binas, A., Nolte, O., Martin, L. L., & Hoffmann, R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100378b · Cited by 137
Dual mode of action of Bac7, a proline-rich antibacterial peptide
Podda, E., Benincasa, M., Pacor, S., Micali, F., Mattiuzzo, M., Gennaro, R., & Scocchi, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.006 · Cited by 136
Casteels, P., & Tempst, P. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1234 · Cited by 134
Sahl, H., & Brandis, H. J. (1981) · Microbiology · doi:10.1099/00221287-127-2-377 · Cited by 128
Yeaman, M. R., Puentes, S. M., Norman, D. C., & Bayer, A. S. (1992) · Infection and Immunity · doi:10.1128/iai.60.3.1202-1209.1992 · Cited by 128
Noore, J., Noore, A., & Li, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01650-12 · Cited by 126
Subbalakshmi, C., Krishnakumari, V., Nagaraj, R., & Sitaram, N. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00996-9 · Cited by 125
Visualizing Attack of Escherichia coli by the Antimicrobial Peptide Human Defensin 5
Chileveru, H. R., Lim, S. A., Chairatana, P., Wommack, A. J., Chiang, I.-L., & Nolan, E. M. (2015) · Biochemistry · doi:10.1021/bi501483q · Cited by 124
Heddle, J. G., Blance, S. J., Zamble, D. B., Hollfelder, F., Miller, D. A., Wentzell, L. M., Walsh, C. T., & Maxwell, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4562 · Cited by 123
GUSMAN, H. D. S., Travis, J. W., Helmerhorst, E. J., Potempa, J., Troxler, R. F., & Oppenheim, F. G. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1402-1408.2001 · Cited by 123
Casteels-Josson, K., Capaci, T. M., Casteels, P., & Tempst, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05801.x · Cited by 115
The FhuA protein is involved in microcin 25 uptake
Salomón, R. A., & Farı́as, R. N. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.23.7741-7742.1993 · Cited by 113
Ghosh, A., Kar, R. K., Jana, J., Saha, A., Jana, B., Krishnamoorthy, J., Kumar, D., Ghosh, S., Chatterjee, S., & Bhunia, A. (2014) · ChemMedChem · doi:10.1002/cmdc.201402215 · Cited by 113
Morphology of defensin-treated Staphylococcus aureus
Shimoda, M., Ohki, K., Shimamoto, Y., & Kohashi, O. (1995) · Infection and Immunity · doi:10.1128/iai.63.8.2886-2891.1995 · Cited by 111
Genetic analysis of plasmid determinants for microcin J25 production and immunity
Solbiati, J., Ciaccio, M., Farías, R. N., & Salomón, R. A. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.12.3661-3663.1996 · Cited by 111
Morphogenesis of Escherichia coli
Vollmer, W. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(01)00261-2 · Cited by 109
Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways
Edgerton, M., Koshlukova, S. E., Araujo, M. W. B., Patel, R. C., Dong, J., & Bruenn, J. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3310-3316.2000 · Cited by 109
Regulation of cell division in E. coli
Lutkenhaus, J. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90045-8 · Cited by 107
Xiong, Y.-Q., Yeaman, M. R., & Bayer, A. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1111 · Cited by 107
Activity of Novel Synthetic Peptides against Candida albicans
Lum, K. Y., Tay, S. T., Le, C. F., Lee, V. S., Sabri, N. H., Velayuthan, R. D., Hassan, H. H., & Sekaran, S. D. (2015) · Scientific Reports · doi:10.1038/srep09657 · Cited by 106
Self-citationInnate immunity, antimicrobial peptides, and protection of the oral cavity
ZASLOFF, M. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11239-6 · Cited by 103
The proteome targets of intracellular targeting antimicrobial peptides
SHAH, P. M., Hsiao, F. S., Ho, Y.-H., & Chen, C. (2015) · PROTEOMICS · doi:10.1002/pmic.201500380 · Cited by 102
Wescombe, P. A., & Tagg, J. R. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.5.2737-2747.2003 · Cited by 96
Casteels, P., Romagnolo, J., Castle, M., Casteels-Josson, K., Erdjument‐Bromage, H., & Tempst, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47165-7 · Cited by 93
Sorsa, T. A., Suomalainen, K., & Uitto, V. J. (1990) · Archives of Oral Biology · doi:10.1016/0003-9969(90)90156-5 · Cited by 93
Nishikata, M., Kanehira, T., Oh, H., Hiroshi, T. A. N. I., Tazaki, M., & Kuboki, Y. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91463-m · Cited by 92
Jindal, H. M., Le, C. F., Yusof, M. Y. M., Velayuthan, R. D., Lee, V. S., Zain, S. M., Isa, D. M., & Sekaran, S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128532 · Cited by 89
Self-citationKnappe, D., Zahn, M., Sauer, U., Schiffer, G., Sträter, N., & Hoffmann, R. (2011) · ChemBioChem · doi:10.1002/cbic.201000792 · Cited by 89
Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli
Laviña, M. D., Gaggero, C., & Moreno, F. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.11.6585-6588.1990 · Cited by 85
Piers, K. L., & Hancock, R. E. W. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01083.x · Cited by 85
Gee, K., Kozlowski, M., & Kumar, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302309200 · Cited by 83
Design of Gram-Negative Selective Antimicrobial Peptides
Muhle, S. A., & Tam, J. P. (2001) · Biochemistry · doi:10.1021/bi0100384 · Cited by 81
Koo, S.-P., Bayer, A. S., Sahl, H., Proctor, R. A., & Yeaman, M. R. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.1070-1074.1996 · Cited by 80
Mechanism and Fitness Costs of PR-39 Resistance in Salmonella enterica Serovar Typhimurium LT2
Pränting, M., Negrea, A., Rhen, M., & Andersson, D. I. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00205-08 · Cited by 76
Ho, Y.-H., SHAH, P. M., Chen, Y.-W., & Chen, C. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.054999 · Cited by 76
The action of the bacterial toxin, microcin B17, on DNA gyrase
Parks, W. M., Bottrill, A. R., Pierrat, O. A., Durrant, M. C., & Maxwell, A. (2007) · Biochimie · doi:10.1016/j.biochi.2006.12.005 · Cited by 75
Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro
Yeaman, M. R., Ibrahim, A. S., Edwards, J. E., Bayer, A. S., & Ghannoum, M. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.546 · Cited by 71
Yeaman, M. R., Norman, D. C., & Bayer, A. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.8.1665 · Cited by 71
Neutron Off-Plane Scattering of Aligned Membranes. I. Method of Measurement
Yang, L., Harroun, T. A., Heller, W. T., Weiss, T. M., & Huang, H. W. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77554-x · Cited by 69
Shi, J. N., Ross, C. R., Chengappa, M. M., & Blecha, F. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.6.807 · Cited by 69
Wanniarachchi, Y. A., Kaczmarek, P., Wan, A., & Nolan, E. M. (2011) · Biochemistry · doi:10.1021/bi201043j · Cited by 68
Frecer, V., Ho, B., & Ding, J. L. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01069.x · Cited by 57
Maria-Neto, S., Cândido, E. D. S., Rodrigues, D. R., Sousa, D. A., Silva, E. M., de Moraes, L. M. P., Otero‐González, A. J., Magalhães, B. S., Dias, S. C., & Franco, O. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05558-11 · Cited by 57
Abel, R. J. V., Tang, Y., Rao, V. S., DOBBS, C. H., TRAN, D., Bárány, G., & Selsted, M. E. (1995) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1995.tb01055.x · Cited by 54
Becucci, L., Valensin, D., Innocenti, M., & Guidelli, R. (2013) · Soft Matter · doi:10.1039/c3sm52400k · Cited by 51
Ho, Y.-H., Sung, T.-C., & Chen, C.-S. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014720 · Cited by 47
Le, C. F., Yusof, M. Y. M., Hassan, H. H., & Sekaran, S. D. (2015) · Scientific Reports · doi:10.1038/srep09761 · Cited by 47
Self-citationViljanen, P., Koski, P., & Vaara, M. (1988) · Infection and Immunity · doi:10.1128/iai.56.9.2324-2329.1988 · Cited by 46
Le, C. F., Gudimella, R., Razali, R., Manikam, R., & Sekaran, S. D. (2016) · Scientific Reports · doi:10.1038/srep26828 · Cited by 43
Self-citationChesnokova, L. S., Slepenkov, S. V., & Witt, S. N. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.075 · Cited by 42
Identification of Lactoferricin B Intracellular Targets Using an Escherichia coli Proteome Chip
Tu, Y.-H., Ho, Y.-H., Chuang, Y.-C., Chen, P.-C., & Chen, C.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028197 · Cited by 37
Neutralization of Endotoxin In Vitro and In Vivo by BAC7(1-35), a Proline-Rich Antibacterial Peptide
Ghiselli, R., Giacometti, A., Cirioni, O., Circo, R., Mocchegiani, F., Skerlavaj, B., D’Amato, G., Scalise, G., Zanetti, M., & Saba, V. (2003) · Shock · doi:10.1097/01.shk.0000055236.26446.c9 · Cited by 37
Combination of antibiotic mechanisms in lantibiotics
Hoffmann, A., Pag, U., Wiedemann, I., et al. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01208-9 · Cited by 36
Le, C. F., Yusof, M. Y. M., Hassan, M. A. A., Lee, V. S., Isa, D. M., & Sekaran, S. D. (2015) · Scientific Reports · doi:10.1038/srep11886 · Cited by 31
Self-citationA Bacterial Mutant Library as a Tool to Study the Attack of a Defensin Peptide
Moser, S., Chileveru, H. R., Tomaras, J., & Nolan, E. M. (2014) · ChemBioChem · doi:10.1002/cbic.201402354 · Cited by 14
Cited by
Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
Huan, Y., Kong, Q., Mou, H., & Yi, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.582779 · Cited by 1,595
Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance
Ghosh, C., Sarkar, P., Issa, R., & Haldar, J. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.12.010 · Cited by 661
Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
Luo, Y., & Song, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111401 · Cited by 559
Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs)
Dijksteel, G. S., Ulrich, M. M. W., Middelkoop, E., & Boekema, B. K. H. L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.616979 · Cited by 428
Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria
Moravej, H., Moravej, Z., Yazdanparast, M., Heiat, M., Mirhosseini, A., Moosazadeh Moghaddam, M., & Mirnejad, R. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0392 · Cited by 410
Metadata
- Authors
- Le, C.-F., Fang, C.-M., & Sekaran, S. D.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2017-04
- Volume
- 61
- Issue
- 4
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2586156886
- Cited by
- 603
- References
- 162
- FWCI
- 26.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.